Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

CEO

Ms. Y. Y. Tse

Employees

25552

Country

Hong Kong

ISIN

KYG8167W1380

Listings

0 Comments

Share your thoughts

FAQ

What is Sino Biopharmaceutical stock price today?▼

The current price of SMZ1.STU is €0.63 EUR — it has decreased by -1.82% in the past 24 hours. Watch Sino Biopharmaceutical stock price performance more closely on the chart.

What is Sino Biopharmaceutical stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Sino Biopharmaceutical stocks are traded under the ticker SMZ1.STU.

Is Sino Biopharmaceutical stock price growing?▼

SMZ1.STU stock has fallen by -8.18% compared to the previous week, the month change is a -4.07% fall, over the last year Sino Biopharmaceutical has showed a +58.58% increase.

When is the next Sino Biopharmaceutical earnings date?▼

Sino Biopharmaceutical is going to release the next earnings report on August 26, 2026.

What were Sino Biopharmaceutical earnings last quarter?▼

SMZ1.STU earnings for the last quarter are 0 EUR per share, whereas the estimation was 0.01 EUR resulting in a -83.33% surprise. The estimated earnings for the next quarter are N/A EUR per share.

How many employees does Sino Biopharmaceutical have?▼

As of April 11, 2026, the company has 25,552 employees.

In which sector is Sino Biopharmaceutical located?▼

Sino Biopharmaceutical operates in the Health & Wellness sector.

When did Sino Biopharmaceutical complete a stock split?▼

Sino Biopharmaceutical has not had any recent stock splits.

Where is Sino Biopharmaceutical headquartered?▼

Sino Biopharmaceutical is headquartered in Wan Chai, Hong Kong.